Good evening :)
Switch to
Place Order

Unichem Laboratories Ltd

UNICHEMLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,956 cr, stock is ranked 666
Moderate RiskStock is 2.89x as volatile as Nifty
368.707.81% (-31.25)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,956 cr, stock is ranked 666
Moderate RiskStock is 2.89x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
89.451.130.95%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.904.360.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Unichem Laboratories Limited is an India-based specialty pharmaceutical company. The Company manufactures and markets pharmaceutical formulations as branded generics as well as generics in various markets across the world. It is engaged in product development, process chemistry, and manufacturing complex active pharmaceutical ingredients (APIs) as well as dosage forms. It offers an array of medicines for therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives, and pain management. The Company has about six plants situated at Roha and Kolhapur, Maharashtra; Pilerne, Goa; Baddi, Himachal Pradesh; Pithampur, Madhya Pradesh and Ghaziabad, Uttar Pradesh. It has a global presence in the United States, United Kingdom, South Africa, Brazil and China. Its subsidiaries include Niche Generics Limited, Unichem Pharmaceuticals (USA), Inc., Unichem SA (Pty) Limited and Unichem (China) Pvt. Ltd., among others.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+1.28+1.20+1.29+1.32-0.02-0.06+0.03+0.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 24, 2022

Unichem Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Unichem Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Loss of share certificate 
Announced OnNov 23, 2022

Unichem Laboratories Limited has informed the Exchange about Duplicate Share Certificate has been issued based on receipt of requisite documentation from the shareholder. | Download

Unichem Laboratories Limited has informed the Exchange about Duplicate Share Certificate has been issued based on receipt of requisite documentation from the shareholder. | Download

Cash Dividend 
Ex. DateAug 1, 2022

Final • Div/Share: ₹ 4

See all events